Open AccessNeratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial
Author(s) -
Ahmad Awada,
Rámón Colomer,
Kenichi Inoue,
Igor Bondarenko,
Rajendra Badwe,
Georgia Demetriou,
Soo Chin Lee,
Ajay Mehta,
SungBae Kim,
Thomas Bachelot,
Chanchal Goswami,
Suryanarayan V.S. Deo,
Ron Bose,
Alvin Wong,
Feng Xu,
Bin Yao,
Richard Bryce,
Lisa A. Carey
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/tfn3-9835
Subject(s) - paclitaxel , trastuzumab , metastatic breast cancer , neratinib , medicine , oncology , breast cancer , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom